Back

Efficacy and safety of potent p2y12 inhibitors versus clopidogrel in complex percutaneous coronary intervention: a systematic review and meta-analysis

1 September 2025 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Pharmacotherapy in acute coronary syndromes (5) Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Francesco Stabile

University Hospital Paolo Giaccone, Palermo (Italy)

3 More presentations in this session

Presentation thumbnail
Prophylactic anticoagulation for left ventricular thrombus in patients with anterior myocardial infarction
Doctor A. Gajulapalli (Stony Brook, US)
Abstract Slides Video
Presentation thumbnail
High-intensity lipid-lowering therapy accelerates early plaque regression: a FLOWPROMOTE sub study.
Doctor N. Iraqi (Aarhus, DK)
Abstract Slides Video
Presentation thumbnail
Impact of beta-blocker carvedilol versus Bisoprolol prescription at discharge on long-term clinical outcomes in STEMI patients with preserved LVEF treated with drug-eluting stents
Professor S. Park (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Pharmacotherapy in acute coronary syndromes (5)

The Event

Event poster

ESC Congress 2025

1 September 2025 09:15 CET
You may be interested in
thumbnail
Congress Presentation
P2Y12 inhibitor monotherapy after short DAPT in acute coronary syndrome: a systematic review and meta-analysis
thumbnail
Congress Presentation
Ticagrelor versus clopidogrel for complex percutaneous coronary intervention in chronic coronary syndrome: a post-hoc analysis of the ALPHEUS study
thumbnail
Congress Presentation
Dual antiplatelet therapy de-escalation followed by aspirin or P2Y12 inhibitor monotherapy after PCI for acute coronary syndrome: a systematic review and meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources